meerecompany closing its symposium to celebrate the 100th robotics surgery in OBGYN



- Professor Keun Ho Lee of the Catholic University of Korea Seoul St. Mary's Hospital gaining "attention" for completing transformed single-port access robot surgery using Revo-i in success

- Busan Queen's Park Women's Hospital shared the latest technology in robotics surgery including the clinical application of Revo-i


meerecompany (CEO Joon Koo Kim) announced on the 7th that it held a symposium to celebrate completing 100 cases of gynecological robotic surgery using Revo-i at Queen's Park Women's Hospital at the Westin Chosun Hotel in Busan on the 2nd by inviting obstetricians and gynecologists.


Presentations on the clinical experiences, know-how and achievements realized by using Revo-i were given at the symposium. During the first session, Beom Ju Choi, General Director of Queen's Park Women's Hospital, gave a presentation with the theme of "Current status of introduction of Revo-i robot surgery." This presentation covered the general affairs of the medical field, including hospital operation plans after applying new technology. During the second session, General Director Jong Woon Bae shared the special features and clinical know-how with regard to Revo-i using actual clinical application cases under the theme of "Clinical cases of Revo-i robot surgery in OBGYN," and various discussions based on the presentation followed.


During the 3rd session, Professor Keun Ho Lee of the OBGYN department of the Catholic University of Korea Seoul St. Mary's Hospital gave a special lecture on the "highly sophisticated robotic surgery performed with Revo-i in gynecology." On October 1, Professor Lee showed the single-port plus one TLH performed with Revo-i during the gynecology Cadaver Workshop and vNOTES Salpingectomy, which is performed through the vagina without skin incision.


Professor Keun Ho Lee of the Catholic University of Korea Seoul St. Mary's Hospital said, "The single-port robotic surgery introduced this time is more significant because it was the first such attempt." He added, "We saw its potential while performing single-port plus one TLH with Revo-i, and we expect great things in the future."


Beom Ju Choi, General Director of Queen's Park Women's Hospital said, "The number of robotic surgeries continues to increase as the various advantages of robotic surgery, such as reduced pain and quicker recovery, are identified. I am very pleased to be able to provide such quality treatment to patients." He expressed his aspirations, adding, "We will continue to promote robotic surgery in the Busan, Ulsan, and Gyeongsang-do areas and strive to become a hub of robotics surgery in this region."


CEO Joon Koo Kim of meerecompany said, "This symposium was held to celebrate the achievement of 100 cases of Revo-i robotic surgery in the field of gynecology and to share the achievements and experience of using Revo-i. It has been meaningful for us to reaffirm the clinical value of Revo-i and share the latest robotic surgery techniques." He added, "We will continue to increase the accessibility of robotic surgery in order to provide the most advanced medical services to more patients using Revo-i."


Meanwhile, Revo-i is the first surgical robot developed and commercialized in Korea. This robot features a high-resolution 3D stereoscopic image, wide view, and multi-joint devices to support fine and delicate motions, expanding its stage of application to high-difficulty surgeries such as prostatectomy, partial nephrectomy, hysterectomy, and thyroidectomy.

Article :